Login / Signup

Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials.

Alberto Enrico MaraoloAdriano Grossi
Published in: Immunity, inflammation and disease (2020)
Safety profile of HCQ appears to be unsatisfactory when used to treat or prevent COVID-19, especially in the light of unproved clinical benefit.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • clinical trial
  • combination therapy
  • quantum dots